Isomorphic Labs closes $5B Series C funding round
11/17/2026 — 11/18, 00:20·9 sources (all)·9 reports (all)·In the 2026-11-17 briefing
Key takeaways
- Alphabet-backed Isomorphic Labs, an AI drug discovery company, has closed a $5B Series C round co-led by Sequoia Capital and Greenoaks, with…
Background & analysis
On the evening of November 17, 2026, Bloomberg Technology first reported that Isomorphic Labs, the Alphabet subsidiary that uses AI to design new drugs, had closed a $5 billion funding round led by Sequoia and Greenoaks, only six months after the company announced its previous fundraising. Techmeme then cited Bloomberg to confirm the round as a $5B Series C co-led by Sequoia and Greenoaks, adding that Isomorphic Labs had previously raised $600M in March 2025 and $2.1B in May, and that the new capital is meant to accelerate clinical trials.
Later the same day, The Next Web reported that the Alphabet drug discovery company, led by Demis Hassabis, had raised $5bn in a Series C round co-led by Greenoaks and Sequoia Capital. Andreessen Horowitz and several other new investors joined the round, which the company described as a continuation of significant investment. The report was published on Tuesday, six months after the $2.1bn round in May.
The accounts agree on the round size and the lead investors, while details such as the stated purpose of the funding and the list of new participants come from separate sources. No further developments regarding the round have been reported since then.
AI-generated from 3 reports · updated 8 hours ago
Latest turnIsomorphic Labs, Alphabet's AI drug discovery company led by Demis Hassabis, has raised $5 billion, six months after a $2.1 billion round, The Decoder reports. The money is meant to push its drug pipeline toward clinical trials; the company has no approved drugs yet.
- Heat index
- 716
- All sources
- 9
- All reports
- 9
- First seen
- 10 hours ago
Reports on this story headlines open the original
Isomorphic Labs, Alphabet's AI drug discovery company led by Demis Hassabis, has raised $5 billion, six months after a $2.1 billion round, The Decoder reports. The money is meant to push its drug pipeline toward clinical trials; the company has no approved drugs yet.
The DecoderAI score 65Isomorphic Labs, the AI drug-discovery company spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C round, TechCrunch reports. The funding is meant to move its drug candidates into clinical trials.
TechCrunch · AIAI score 58Isomorphic Labs, the AI drug discovery company founded by Demis Hassabis, has raised $5 billion, CNBC reports. The company aims to develop new medicines using AI. The round comes months after Hassabis stepped down as CEO of Google DeepMind.
CNBC · 科技AI score 64Isomorphic Labs, the UK AI drug discovery company founded by Demis Hassabis, has closed a $5 billion Series C that was oversubscribed, according to Zhi Dongxi. Greenoaks and Sequoia Capital co-led the round, with a16z and other new investors joining and Alphabet investing heavily again; the size may set a record for AI drug discovery.
智东西AI score 63Isomorphic Labs, Alphabet's AI drug discovery company led by Demis Hassabis, has raised a $5 billion Series C round co-led by Greenoaks and Sequoia Capital, with a16z joining as a new investor. The company plans to use the funds to advance its foundational simulation models, scale internal and partnered drug programs, and build global AI-driven bioengineering infrastructure.
IT之家AI score 70According to The Next Web, Isomorphic Labs, the Alphabet-backed AI drug discovery company led by Demis Hassabis, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and others.
The Next WebAI score 75Isomorphic Labs, the AI drug discovery company founded by Demis Hassabis, has raised $5 billion in Series C funding from Greenoaks, Sequoia Capital and Andreessen Horowitz, with continued investment from Alphabet, according to TestingCatalog. The company focuses on designing and developing new medicines with AI.
X:TestingCatalog (@testingcatalog)AI score 56According to Bloomberg, Alphabet's AI drug design startup Isomorphic Labs has raised a $5 billion Series C round led by Sequoia and Greenoaks to accelerate its clinical trials.
TechmemeAI score 65Alphabet-backed Isomorphic Labs has secured $5 billion in a new funding round led by Sequoia Capital and Greenoaks. The AI-driven drug discovery company raised the capital just six months after its previous fundraising effort.
Bloomberg TechnologyAI score 65
Other stories people are talking about
- Heat index 1406Nvidia board establishes national security and export control committee26 sources
- Heat index 1066California Sues OpenAI Over Agent Intrusion Into Hugging Face19 sources
- Heat index 969NewSurgeJensen Huang says he would return as Nvidia CEO and agrees to testify on Capitol Hill11 sources
- Heat index 931NewOpenAI Launches GPT-6.2 Astra and Sol on ChatGPT and API10 sources
- Heat index 863RisingAnthropic guides IPO pricing at or above the $70-$78 range, trading set for Nov 1911 sources
How is heat calculated?About the methodHide
Heat counts how many independent sources covered a story in the last 48 hours: one source counts once no matter how many posts it published, decaying with a 24-hour half-life. What ranks first is what many people are talking about.
This page aggregates public feeds. Headlines and summaries are machine-organized and remain the property of the original authors; verify important facts at the source. If you believe a headline or summary infringes your rights, email the contact address in the footer with the page URL and basis of your claim, and we will remove or replace it after review.
- Surge
- Discussion rising fast
- New
- First report within 6 hours
- Rising
- Still gathering discussion

